A retrospective Italian Society of Veterinary Oncology (SIONCOV) study of 56 cats with appendicular osteosarcoma.

appendicular feline metastatic rate osteosarcoma prognosis

Journal

Veterinary and comparative oncology
ISSN: 1476-5829
Titre abrégé: Vet Comp Oncol
Pays: England
ID NLM: 101185242

Informations de publication

Date de publication:
07 Feb 2024
Historique:
revised: 24 01 2024
received: 06 12 2023
accepted: 25 01 2024
medline: 8 2 2024
pubmed: 8 2 2024
entrez: 8 2 2024
Statut: aheadofprint

Résumé

Osteosarcoma is the most common malignant primary bone cancer, but it is infrequently reported in cats. Feline appendicular osteosarcoma typically exhibits good prognosis when treated with surgery alone. A retrospective multi-institutional study was conducted to identify possible prognostic factors. Cats diagnosed with appendicular osteosarcoma were included if initial staging and follow-up information were available. Data including signalment, tumour characteristics, treatment modalities, and survival outcomes were collected and analysed. Fifty-six cats were included; the femur was the most frequently affected bone. Eight cats had distant metastasis at admission and an additional 9 developed metastatic disease during follow-up, resulting in an overall metastatic rate of 30%. Forty-nine (87.5%) cats underwent surgery, and 4 also received adjuvant chemotherapy. Among operated cats, median time to local progression (TTLP), time to distant progression and tumour-specific survival (TSS) were not reached. One- and 2-year survival rates were 66% and 55%, respectively. Seven (12.5%) cats received no treatment; 1- and 2-year survival rates were 25% and 0%, respectively. Operated cats had significantly longer TTLP (P < .001) and TSS (P = .001) compared with non-operated cats. Among operated cats, young age negatively impacted local tumour progression, while the presence of distant metastasis at diagnosis was associated with a higher risk of tumour-related death. This study reaffirms the good prognosis for cats with appendicular osteosarcoma undergoing surgery, but sheds light on some additional factors to consider. Accurate initial staging is recommended, as the metastatic rate may exceed many previous estimations. Surgery substantially extends survival time, whereas the role of chemotherapy remains uncertain.

Identifiants

pubmed: 38327132
doi: 10.1111/vco.12966
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 John Wiley & Sons Ltd.

Références

Heldmann E, Anderson MA, Wagner-Mann C. Feline osteosarcoma: 145 cases (1990-1995). J Am Anim Hosp Assoc. 2000;36(6):518-521.
Boerman I, Selvarajah GT, Nielen M, Kirpensteijn J. Prognostic factors in canine appendicular osteosarcoma-a meta-analysis. BMC Vet Res. 2012;8(1):1-12.
Nakano Y, Kagawa Y, Shimoyama Y, et al. Outcome of appendicular or scapular osteosarcoma treated by limb amputation in cats: 67 cases (1997-2018). J Am Vet Med Assoc. 2021;260(S1):24-28.
Dimopoulou M, Kirpensteijn J, Moens H, Kik M. Histologic prognosticators in feline osteosarcoma: a comparison with phenotypically similar canine osteosarcoma. Vet Surg. 2008;37(5):466-471.
Turrel JM, Pool RR. Primary bone tumors in the cat: a retrospective study of 15 cats and a literature review. Vet Radiol. 1982;23(4):152-166.
Kessler M, Tassani-Prell M, Von Bomhard D, Matis U. Osteosarcoma in cats: epidemiological, clinical and radiological findings in 78 animals (1990-1995). Tierarztliche Praxis. 1997;25(3):275-283.
Ehrhart NP, Christensen NI, Fan TM. Tumors of the skeletal system. In: Vail DM, Thamm DH, Liptak JM, eds. Withrow and MacEwen's Small Animal Clinical Oncology. 6th ed. Saunders Elsevier; 2020:553-555.
Liu S, Dorfman HD, Patnaik AK. Primary and secondary bone tumours in the cat. J Small Anim Pract. 1974;15(3):141-156.
Bitetto WV, Patnaik AK, Schrader SC, Mooney SC. Osteosarcoma in cats: twenty-two cases (1974-1984). J Am Vet Med Assoc. 1987;190(1):91-93.
Barger A, Graca R, Bailey K, et al. Use of alkaline phosphatase staining to differentiate canine osteosarcoma from other vimentin-positive tumors. Vet Pathol. 2005;42(2):161-165.
Kok MK, Chambers JK, Tsuboi M, et al. Retrospective study of canine cutaneous tumors in Japan, 2008-2017. J Vet Med Sci. 2019;81(8):1133-1143.
Matsuda T, Matsuo K, Sawada N, Inoue M. International strategy in cancer epidemiology: Japan's involvement in global projects and future role. Glob Health Med. 2021;3(4):187-195.
Spodnick GJ, Berg J, Rand WM, et al. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). J Am Vet Med Assoc. 1992;200(7):995-999.
Saam DE, Liptak JM, Stalker MJ, Chun R. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006). J Am Vet Med Assoc. 2011;238(2):195-206.
Phillips B, Powers BE, Dernell WS, et al. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs. J Am Anim Hosp Assoc. 2009;45(1):33-38.
Liptak JM, Dernell WS, Ehrhart N, Lafferty MH, Monteith GJ, Withrow SJ. Cortical allograft and endoprosthesis for limb-sparing surgery in dogs with distal radial osteosarcoma: a prospective clinical comparison of two different limb-sparing techniques. Vet Surg. 2006;35(6):518-533.
Moore AS, Dernell WS, Ogilvie GK, et al. Doxorubicin and BAY 12-9566 for the treatment of osteosarcoma in dogs: a randomized, double-blind, placebo-controlled study. J Vet Intern Med. 2007;21(4):783-790.
Kent MS, Strom A, London CA, Seguin B. Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb-sparing surgery in the treatment of appendicular osteosarcoma in dogs. J Vet Intern Med. 2004;18(4):540-544.
Selvarajah GT, Kirpensteijn J, van Wolferen ME, Rao NA, Fieten H, Mol JA. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times. Mol Cancer. 2009;8:72.
Huang J, McFadden KK, Powers A, Burnum AL, de Oliveira CF. What is your diagnosis? Fine-needle aspirate from an intestinal mass in a cat. Vet Clin Pathol. 2022;51(3):444-448.

Auteurs

Laura Marconato (L)

Department of Veterinary Medical Sciences, University of Bologna, Ozzano Emilia, Italy.

Maurizio Annoni (M)

AniCura Clinica Veterinaria Tibaldi, Milan, Italy.

Federico Massari (F)

Clinica Veterinaria Nervianese, Nerviano, Milan, Italy.

Stefano Zanardi (S)

Department of Veterinary Medical Sciences, University of Bologna, Ozzano Emilia, Italy.

Damiano Stefanello (D)

Department of Veterinary Medicine and Animal Sciences, University of Milan, Milan, Italy.

Roberta Ferrari (R)

Department of Veterinary Medicine and Animal Sciences, University of Milan, Milan, Italy.

Federica Rossi (F)

Anicura Clinica Veterinaria dell'Orologio, Sasso Marconi, Bologna, Italy.

Vincenzo Montinaro (V)

Clinica Veterinaria Malpensa Anicura, Samarate (Va), Italy.

Emanuela Morello (E)

Department of Veterinary Sciences, University of Torino, Torino, Italy.

Carmit Chalfon (C)

Centro Veterinario Torinese, Turin, Italy.

Marco De Lorenzi (M)

Clinica Veterinaria Vezzoni, Cremona, Italy.

Daniela Murgia (D)

Dick White Referrals Veterinary Specialists, Six Mile Bottom, UK.

Dario Drudi (D)

Clinica Veterinaria Nervianese, Nerviano, Milan, Italy.

Gabriele Truncellito (G)

Department of Veterinary Medical Sciences, University of Bologna, Ozzano Emilia, Italy.

Emanuele Cabibbo (E)

VetPartners Vetcenter Ospedale Veterinario, Parma, Italy.

Silvia Sabattini (S)

Department of Veterinary Medical Sciences, University of Bologna, Ozzano Emilia, Italy.

Classifications MeSH